Inactive Instrument

Allkem

Equities

AKE

AU0000193666

Orocobre Limited Provides Impairment Charges Guidance for the Year Ended June 30, 2020

July 30, 2020 at 10:19 am EDT

Orocobre Limited provided impairment charges guidance for the year ended June 30, 2020. The company expects to recognise a non-cash, pre-tax impairment charge of approximately $28 million in its 30 June 2020 annual results.

Latest news about Allkem

Allkem to be Delisted from Toronto Bourse	Jan. 04	MT
Allkem to be Removed from Australian Bourse's Official List	Jan. 04	MT
Arcadium Lithium plc Appoints Paul W. Graves as Chief Executive Officer	Jan. 04	CI
Arcadium Lithium plc Appoints Gilberto Antoniazzi as Chief Financial Officer	Jan. 04	CI
Livent Corporation, Livent USA Corp., Arcadium Lithium Plc, Arcadium Lithium Financing IRL Limited and Irish IntermediateCo Enter into A Joinder and First Amendment to Certain Amended and Restated Credit Agreement with Citibank, N.A	Jan. 04	CI
Allkem Says COMEX Approval Granted for James Bay	Dec. 28	MT
North American Morning Briefing : S&P 500 Futures Just Shy of Record High	Dec. 28	DJ
Allkem Secures Environmental Approval for James Bay Project Development	Dec. 28	MT
Arcadium Lithium's Scheme to Acquire Allkem Takes Effect	Dec. 26	MT
Allkem Limited(ASX:AKE) dropped from S&P Global BMI Index	Dec. 22	CI
Allkem Limited(ASX:AKE) dropped from S&P/ASX 100 Index	Dec. 22	CI
Allkem Limited(ASX:AKE) dropped from S&P/ASX 200 Materials Sector Index	Dec. 22	CI
Allkem Limited(ASX:AKE) dropped from S&P/ASX 200 Index	Dec. 22	CI
Allkem Limited(ASX:AKE) dropped from S&P/ASX All Ordinaries Index	Dec. 22	CI
Allkem Limited(ASX:AKE) dropped from S&P/ASX 300 Index	Dec. 22	CI
Livent, Allkem Shareholders Approve $10.6 Billion Merger	Dec. 19	MT
Global markets live: Apple, AbbVie, Comcast, FMC Accenture...	Dec. 19
Investors got more clues that rate cuts are imminent	Dec. 19
Livent Secures Allkem Shareholders' Approval for Planned Business Combination	Dec. 19	MT
Allkem Limited Brief: Said Shareholders Vote in Favour of Merger with Livent	Dec. 19	MT
Allkem shareholders vote in favour of $10.6 bln Livent merger	Dec. 18	RE
Allkem investors approve Livent $10.6 bln merger on proxy votes	Dec. 18	RE
Transcript : Allkem Limited - Shareholder/Analyst Call	Dec. 18
Allkem shareholders set to vote on Livent's $10.6 bln merger bid	Dec. 18	RE
Allkem Signs Kapisikama Agreement to Develop James Bay Lithium Project	Dec. 15	MT

Chart Allkem

Duration

Period

More charts

Company Profile

Allkem Limited is a specialty lithium chemicals company with a global portfolio of lithium chemicals. The Company is principally engaged in mineral extraction, production, and chemical processing. The Company's segments include Olaroz, Mt Cattlin, James Bay, Sal De Vida projects, and Corporate. Its flagship Olaroz brine-based lithium facility is based in Northern Argentina and supplies lithium chemicals across the globe. The Mt Cattlin spodumene project (Mt Cattlin) produces spodumene concentrate utilizing conventional techniques to extract and process the resource. This wholly owned project is located two kilometers (km) north of the town of Ravensthorpe in Western Australia. The James Bay Project is located in northern Quebec, approximately 130 km east of James Bay and the Cree Nation of Eastmain community. Sal De Vida project is a tier one brine project, which is located in Catamarca Province on the Salar del Hombre Muerto. Its other project includes Cauchari mineral resource.

Sector

More about the company